Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SafelyBack appears to be a private, active company focused on personal safety monitoring and digital status-tracking tools rather than therapeutics development. Its legacy offering is described as a personal safety monitoring system designed to confirm that a person has returned safely and to alert designated contacts if a problem occurs. More recent materials also connect SafelyBack to "SafelyThrive," a COVID-19 screening, testing, tracing, and operational health-safety platform for schools and organizations. Based on available public information, the company operates in digital health and safety infrastructure, using software, mobile apps, notifications, and identity/status verification rather than developing drugs or biologic products. It does not appear to be a biotech or pharma company with a traditional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SafelyBack.